Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
10.07.25
/
50%
€26.00
Target price
10.07.26
€55.35
Performance (%)
-22.31%
Price
05.02.26
€20.20
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -22.31%. This prediction currently runs until 10.07.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% |
| iShares Core DAX® | -0.197% | -1.724% |
| iShares Nasdaq 100 | -3.612% | -3.768% |
| iShares Nikkei 225® | 1.176% | 2.165% |
| iShares S&P 500 | -0.825% | -1.916% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Wells Fargo & Company from $88.00 to $65.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€38.21
30.12.26
30.12.26
18.82%
05.02.26
05.02.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€29.20
20.10.25
20.10.25
€55.74
20.10.26
20.10.26
-30.82%
05.02.26
05.02.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.80
20.12.24
20.12.24
€84.54
20.12.25
20.12.25
-32.06%
21.12.25
21.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.20
02.08.24
02.08.24
€68.71
02.08.25
02.08.25
-46.75%
03.08.25
03.08.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24